These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17223795)

  • 21. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
    Mullins C; Kaplan SA
    J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
    Jaillon P
    Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
    Piccini JP; Whellan DJ; Berridge BR; Finkle JK; Pettit SD; Stockbridge N; Valentin JP; Vargas HM; Krucoff MW;
    Am Heart J; 2009 Sep; 158(3):317-26. PubMed ID: 19699852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resource allocation to brain research in Europe (RABRE).
    Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
    Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug costs: research and development costs: the great illusion.
    Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding pharmacology in humans: Phase I and Phase II (data generation).
    Merlo Pich E
    Curr Opin Pharmacol; 2011 Oct; 11(5):557-62. PubMed ID: 21783419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research.
    Rogers J; Carolin T; Vaught J; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):32-8. PubMed ID: 21672893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
    Eichler HG; Kong SX; Grégoire JP
    Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug industry in "depression".
    Almog DM
    Med Sci Monit; 2005 Jan; 11(1):SR1-4. PubMed ID: 15614206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational research in oncology: key bottlenecks and new paradigms.
    Simon R
    Expert Rev Mol Med; 2010 Oct; 12():e32. PubMed ID: 20929594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging the translation gap - new hopes, new challenges.
    Tageja N
    Fundam Clin Pharmacol; 2011 Apr; 25(2):163-71. PubMed ID: 21155875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who's paying for new drugs?
    Oldham RK
    Nature; 1988 Apr; 332(6167):795. PubMed ID: 3282177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical issues in funding orphan drug research and development.
    Gericke CA; Riesberg A; Busse R
    J Med Ethics; 2005 Mar; 31(3):164-8. PubMed ID: 15738438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.